Pesquisar
Teva Pharmaceutical Industries Ltd
TEVAAdicionar à lista de desejos
33.210USD
+1.010+3.14%
Fechamento 06/23, 16:00（ET）Cotações atrasadas em 15 min
38.24BValor de mercado
26.97P/L TTM
Mais detalhes de Teva Pharmaceutical Industries Ltd Empresa
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Informações de Teva Pharmaceutical Industries Ltd
Código da empresaTEVA
Nome da EmpresaTeva Pharmaceutical Industries Ltd
Data de listagemFeb 06, 2087
CEOFrancis (Richard D)
Número de funcionários33892
Tipo de títulosDepository Receipt
Fim do ano fiscalFeb 06
Endereço124 Dvora Hanevi'a St.
CidadeTEL AVIV-YAFO
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísIsrael
Código postal6944020
Telefone97239148213
Sitehttps://www.tevapharm.com/
Código da empresaTEVA
Data de listagemFeb 06, 2087
CEOFrancis (Richard D)
Executivos da empresa Teva Pharmaceutical Industries Ltd
Nome
Nome/Posição
Posição
Ações detidas
Variação
Prof. Varda Shalev
Prof. Varda Shalev
Independent Director
Independent Director
22.50K
+42.80%
Mr. Chen Lichtenstein
Mr. Chen Lichtenstein
Independent Director
Independent Director
14.49K
--
Ms. Christine (Chris) Fox
Ms. Christine (Chris) Fox
Executive Vice President - U.S. Commercial
Executive Vice President - U.S. Commercial
14.28K
--
Mr. Amir Elstein
Mr. Amir Elstein
Independent Director
Independent Director
--
--
Mr. Mark Sabag
Mr. Mark Sabag
Executive Vice President - International Markets Commercial
Executive Vice President - International Markets Commercial
--
--
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Rosemary A. (Rose) Crane
Ms. Rosemary A. (Rose) Crane
Independent Director
Independent Director
--
--
Mr. Gerald M. (Jerry) Lieberman
Mr. Gerald M. (Jerry) Lieberman
Independent Director
Independent Director
--
--
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
--
--
Mr. Roberto A. Mignone
Mr. Roberto A. Mignone
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Prof. Varda Shalev
Prof. Varda Shalev
Independent Director
Independent Director
22.50K
+42.80%
Mr. Chen Lichtenstein
Mr. Chen Lichtenstein
Independent Director
Independent Director
14.49K
--
Ms. Christine (Chris) Fox
Ms. Christine (Chris) Fox
Executive Vice President - U.S. Commercial
Executive Vice President - U.S. Commercial
14.28K
--
Mr. Amir Elstein
Mr. Amir Elstein
Independent Director
Independent Director
--
--
Mr. Mark Sabag
Mr. Mark Sabag
Executive Vice President - International Markets Commercial
Executive Vice President - International Markets Commercial
--
--
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Perguntas frequentes
Quem são os cinco principais acionistas de Teva Pharmaceutical Industries Ltd?
Os cinco principais acionistas de Teva Pharmaceutical Industries Ltd são: Prof. Varda Shalev
Quantas instituições possuem ações da Teva Pharmaceutical Industries Ltd (TEVA)?
Em 2026Q1, 1226 instituições possuíam ações da Teva Pharmaceutical Industries Ltd, com valor de mercado aproximado de 725.07M, representando 62.27% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 9191465.00.
Qual é a maior fonte de receita da Teva Pharmaceutical Industries Ltd?
Em 2026Q1, o segmento de negócios Generic products gerou a maior receita para Teva Pharmaceutical Industries Ltd, totalizando 9.42B e representando 54.59% da receita total.
